Ruud G.P.M. van Stiphout

Ruud G.P.M. van Stiphout

University of Oxford

H-index: 26

Europe-United Kingdom

About Ruud G.P.M. van Stiphout

Ruud G.P.M. van Stiphout, With an exceptional h-index of 26 and a recent h-index of 19 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of Artificial Intelligence, (Preventive) Health, Digital Twin Technology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Predicting resilience from psychological and physiological daily-life measures

WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma

The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms In Vitro and in a First-In-Human Phase I Clinical Trial

From bench to bedside: Using ProTide chemistry to transform 3'-deoxyadenosine into the novel anti-cancer agent Nuc-7738

Quantitative genetic screening reveals a Ragulator-FLCN feedback loop that regulates the mTORC1 pathway

Ruud G.P.M. van Stiphout Information

University

Position

Post-doctoral researcher

Citations(all)

7496

Citations(since 2020)

4977

Cited By

4407

hIndex(all)

26

hIndex(since 2020)

19

i10Index(all)

32

i10Index(since 2020)

25

Email

University Profile Page

University of Oxford

Google Scholar

View Google Scholar Profile

Ruud G.P.M. van Stiphout Skills & Research Interests

Artificial Intelligence

(Preventive) Health

Digital Twin Technology

Top articles of Ruud G.P.M. van Stiphout

Title

Journal

Author(s)

Publication Date

Predicting resilience from psychological and physiological daily-life measures

Florian Krause

Judith van Leeuwen

Sophie Bögemann

Rayyan Tutunji

Karin Roelofs

...

2023/7

WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma

Cellular Oncology

Nicholas Coupe

Lina Guo

Esther Bridges

Leticia Campo

Olivia Espinosa

...

2023/4

The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms In Vitro and in a First-In-Human Phase I Clinical Trial

Clinical Cancer Research

Hagen Schwenzer

Erica De Zan

Mustafa Elshani

Ruud Van Stiphout

Mary Kudsy

...

2021/12/1

From bench to bedside: Using ProTide chemistry to transform 3'-deoxyadenosine into the novel anti-cancer agent Nuc-7738

Hagen Schwenzer

Michaela Serpi

Valentina Ferrari

James Chettle

Josephine Morris

...

2021/7/1

Quantitative genetic screening reveals a Ragulator-FLCN feedback loop that regulates the mTORC1 pathway

Science Signaling

Erica De Zan

Ruud van Stiphout

Bianca V Gapp

Vincent A Blomen

Thijn R Brummelkamp

...

2020/9/15

See List of Professors in Ruud G.P.M. van Stiphout University(University of Oxford)